New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators

Targeted delivery of potent inhibitor of cytokine/pain-mediator into inflammatory or pain-sensing cells is a promising avenue for treating chronic pain, a world-wide major healthcare burden. An unmet need exists for a specific and effective delivery strategy. Herein, we describe a new approach using...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Minhong, Meng, Jianghui, Wang, Jiafu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981458/
https://www.ncbi.nlm.nih.gov/pubmed/31906003
http://dx.doi.org/10.3390/ijms21010262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981458/
https://www.ncbi.nlm.nih.gov/pubmed/31906003
http://dx.doi.org/10.3390/ijms21010262

Ejemplares similares